Skip to content

UnitedHealth Group UNH Return on equity

Return on equity at other companies

Humana logo
HumanaHUM
18.2%+0.9pp
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
Centene logo
CenteneCNC
-26.1%-38.7pp
Elevance Health logo
Elevance HealthELV
12.1%-2.1pp
Cigna logo
CignaCI
15%+2.8pp
Cencora logo
CencoraCOR
130.6%-99.8pp

Other financials

Income statement

See full
Revenue$111.72B+2.0%
Gross profit$98.9B+1.8%
Operating income$9.0B-1.4%
Net income$6.3B-0.2%
EPS (diluted)$6.90+0.7%

Balance sheet

See full
Cash & equivalents$28.0B-8.8%
Total debt$77.9B-4.1%
Total equity$103.90B+3.1%
Total assets$312.64B+0.9%

Cash flow

See full
Operating cash flow$8.9B+63.3%
CapEx$763.0M-15.0%
Free cash flow$8.1B+78.8%

Valuation

See full
Market cap$362.83B-48.7%
Enterprise value$412.75B-44.2%
P/E30.1×-1.9×
P/S0.8×-0.9×

Profitability

See full
Gross margin88.6%+0.4pp
Operating margin4.2%-4.0pp
Net margin2.7%-2.7pp

Returns & leverage

See full
Debt / equity0.8×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Calculated from UnitedHealth Group’s reported figures.

Based on trailing twelve months.

The official record: UnitedHealth Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about UnitedHealth Group's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UnitedHealth Group's return on equity?
UnitedHealth Group (UNH) reported return on equity of 11.8% in Q1 2026.
How has UnitedHealth Group's return on equity changed year-over-year?
UnitedHealth Group's return on equity decreased by 48.6% year-over-year, from 22.9% to 11.8%.
What is the long-term trend for UnitedHealth Group's return on equity?
Over 4 years (2021 to 2025), UnitedHealth Group's return on equity has grown at a -5.5% compound annual growth rate (CAGR), from 93% to 74.3%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.